These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1810574)

  • 1. Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent.
    Wegner C; Nau H
    Reprod Toxicol; 1991; 5(6):465-71. PubMed ID: 1810574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse.
    Trotz M; Wegner C; Nau H
    Life Sci; 1987 Jul; 41(1):103-10. PubMed ID: 3110521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.
    Wegner C; Nau H
    Neurology; 1992 Apr; 42(4 Suppl 5):17-24. PubMed ID: 1574172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
    Elmazar MM; Thiel R; Nau H
    Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
    Elmazar MM; Nau H
    Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
    Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of folate supplementation on the risk of spontaneous and induced neural tube defects in Splotch mice.
    Gefrides LA; Bennett GD; Finnell RH
    Teratology; 2002 Feb; 65(2):63-9. PubMed ID: 11857507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
    Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
    Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim potentiates valproic acid-induced neural tube defects (NTDs) in mice.
    Elmazar MM; Nau H
    Reprod Toxicol; 1993; 7(3):249-54. PubMed ID: 8318756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse.
    Nau H
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):243-50. PubMed ID: 3927520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc concentrations in mouse embryo and maternal plasma. Effect of valproic acid and nonteratogenic metabolite.
    Wegner C; Drews E; Nau H
    Biol Trace Elem Res; 1990 Jun; 25(3):211-7. PubMed ID: 1698419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-induced neural tube defects.
    Nau H
    Ciba Found Symp; 1994; 181():144-52; discussion 152-60. PubMed ID: 8005022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol potentiates valproic acid-induced neural tube defects (NTDs) in mice due to toxicokinetic interactions.
    Elmazar MM; Nau H
    Reprod Toxicol; 1995; 9(5):427-33. PubMed ID: 8563186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine valproate exposure is associated with alterations in hippocampal cell numbers and folate metabolism in a rat model of valproate teratogenicity.
    Semmler A; Frisch C; Bleul C; Smith D; Bigler L; Prost JC; Blom H; Linnebank M
    Seizure; 2017 Mar; 46():7-12. PubMed ID: 28212902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadmium-induced neural tube defects and fetal growth restriction: Association with disturbance of placental folate transport.
    Zhang GB; Wang H; Hu J; Guo MY; Wang Y; Zhou Y; Yu Z; Fu L; Chen YH; Xu DX
    Toxicol Appl Pharmacol; 2016 Sep; 306():79-85. PubMed ID: 27417525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
    Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
    Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.